Longeveron Inc-A

Penny Stocks Biotech Stocks Healthcare Stocks

$0.74

+0.04 (+6.06%)

As of Aug 14, 10:23 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +3,642.4% upside

Low Target $21.92

Average Target $27.69

High Target $40.08

Current Price $0.74

Current
$0.74

Target
$27.69

$21.92 $27.69 avg $40.08

Scenario Analysis

Bear Case

$21.92

2,862.6%

Low target

Base Case

$27.69

+3,642.4%

Avg target

Bull Case

$40.08

+5,316.9%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$1.58

-53.2% from high

52-Week Low

$0.48

+55.8% from low

Target vs 52W High

$27.69

+1,652.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%